Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Origin Agritech Establishes Biotechnology Service Consortium to Accelerate Licensing and Commercialization of GMO and Gene Editing Technologies 2024-10-21 19:30
NIANCE Unveils Groundbreaking White Paper on Beauty and Longevity: Addressing the 12 Hallmarks of Aging 2024-10-21 15:48
Great Bay Bio Intelligent Drug Development Ecosystem Officially Launched 2024-10-21 13:57
MicuRx Pharmaceuticals Showcases the Pipeline Status of MRX-5 and MRX-8 at BIO Investor Forum 2024-10-18 22:09
LaNova Medicines Announces Initiation of Phase 1 Clinical Trial of Anti-PD-1/VEGF Bispecific Antibody LM-299 and Completion of $42 Million Series C1 Financing 2024-10-18 18:00
111 to Announce Third Quarter 2024 Unaudited Financial Results on November 28, 2024 - Conference Call to Follow 2024-10-18 17:00
Exclusive Interview with Lang Guojun, founder of Sanyou Bio: The Key to Breaking the Bottleneck of New Drug Innovation--The Past and Future of the Super-Trillion Molecule Library 2024-10-17 22:00
Chipscreen Biosciences' Innovative Anti-Tumor Drug CS231295 Tablets: Investigational New Drug (IND) Application Accepted 2024-10-17 21:38
Amplo Biotechnology Announces Three Presentations at the European Society of Gene and Cell Therapy 31st Annual Congress 2024-10-17 18:39
KIND Announces Late-Breaking Abstract Accepted for Presentation on AND017 Clinical Trials to Treat Anemia in Chronic Kidney Disease (CKD) at ASN - Kidney Week 2024 2024-10-17 15:44
WuXi Biologics Receives ESG Corporate Platinum Award from The Asset for Fourth Consecutive Year 2024-10-16 20:00
IGCS Late Breaking Abstract and The Lancet: Akeso Published Positive PFS and OS Results from Phase 3 First-Line Study of Cadonilimab in Cervical Cancer 2024-10-16 19:02
TenNor Announces More than 300 Million RMB Financing to Support Development and Commercialization of Late-Stage Assets Including Rifasutenizol for Heliobacter pylori Infections 2024-10-16 18:00
Join the GenScript Biotech Global Forum: Unlocking Innovations in Cell and Gene Therapies 2024-10-16 17:43
PharmAust affirms corporate strategy with name change to Neurizon Therapeutics 2024-10-16 04:14
Chiglitazar for the Treatment of MASH Phase II Clinical Study Selected for Oral Presentation at the 2024 American Liver Disease Annual Meeting 2024-10-15 22:08
Neurophet-AriBio to develop 'Next-Gen Platform for Alzheimer's diagnosis' 2024-10-15 21:00
Bloomage Debuts New Products at CPHI Milan to Reinforce Its Commitment to Innovation 2024-10-15 21:00
PharmAbcine Announces Safety Approval for 4mg Single-dose Cohort in Phase 1 Clinical Trial of PMC-403 for Neovascular Age-related Macular Degeneration 2024-10-15 09:51
Illuma, Global Pioneer in HMO Research, Launches Traceability Journey in Switzerland, Unveiling Next-Generation HMO Innovations 2024-10-14 23:31
1 3 4 5 6 7 222